End-of-day quote
Other stock markets
|
||
- RON | - |
06/06 | Antibiotice S.A. announced that it expects to receive $108.96 million in funding | CI |
15/05 | Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
RON in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 366 | 100.0 % | 483 | 100.0 % | +31.80% |
Sales per region
RON in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Romania
100.0
%
| 366 | 100.0 % | 483 | 100.0 % | +31.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ioan Nani
CEO | Chief Executive Officer | 64 | 01/87/01 |
Director of Finance/CFO | 56 | 01/91/01 | |
Cornelia Moraru
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/03/05 |
Investor Relations Contact | - | - | |
Mihaela Murariu
HRO | Human Resources Officer | 46 | 07/22/07 |
Liviu Vatavu
LAW | General Counsel | 51 | 09/19/09 |
Ovidiu Bataga
SAM | Sales & Marketing | 46 | 01/01/01 |
Vasile Chebac
PRN | Corporate Officer/Principal | 69 | 01/72/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ioan Nani
CEO | Chief Executive Officer | 64 | 01/87/01 |
Mihai Trifu
BRD | Director/Board Member | 41 | 26/21/26 |
Director/Board Member | 48 | 26/21/26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 671,338,040 | 117,937,079 ( 17.57 %) | 0 | 17.57 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+41.30% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.60% | 246B | |
-0.04% | 225B | |
+10.46% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- ATB Stock
- Stock
- Company Antibiotice SA